Friedreich Ataxia Trial, Recruiting NCT02316314 Sponsor: Weill Medical College of Cornell University Condition: Friedreich Ataxia
Back to Friedreich Ataxia

Friedreich Ataxia Trial, Recruiting

NCT02316314
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

For people with Friedreich's Ataxia (FRDA):

Who might be able to join this trial:

  • You are male or female, between 12 and 50 years old
  • You are willing and able to give your consent to participate (teenagers will need to give their own agreement, and a parent must also give consent)
  • You have a confirmed diagnosis of Friedreich's Ataxia, based on your symptoms and genetic test results
  • Your heart's pumping strength (measured by an ultrasound of the heart) is above a certain level — if you haven't had this test recently, it will be done before you join

Who may not be able to join:

  • You have signs or symptoms of heart failure
  • You have moderate to severe irregular heart rhythms
  • You have a history of chest pain caused by reduced blood flow to the heart (angina)
  • You have an implanted pacemaker, defibrillator, or any other device that would prevent you from having an MRI scan
  • You are on dialysis, have significantly reduced kidney function, or have a sudden kidney injury (if a recent kidney test isn't available, one will be done before your MRI)
  • You are pregnant
  • You have taken part in a study involving an experimental drug or device recently, or are currently enrolled in one
  • You are unable to have a cardiac MRI scan using a special dye (contrast), or you have claustrophobia (fear of enclosed spaces)
  • You have been diagnosed with Type 1 or Type 2 Diabetes
  • You have any other condition or health issue that the study doctor believes would make it unsafe or unsuitable for you to participate (confirm with trial site)

For healthy volunteers (normal controls):

Who might be able to join this trial:

  • You are male or female, between 12 and 30 years old
  • You are willing and able to give your consent to participate (teenagers will need to give their own agreement, and a parent must also give consent)
  • Your age, gender, and ethnicity are similar to those of participants in the Friedreich's Ataxia group
  • You are able to complete the various heart assessment tests involved in the study
  • Your heart's pumping strength (measured by an ultrasound of the heart) is above a certain level — if you haven't had this test recently, it will be done before you join

Who may not be able to join:

  • The study doctor does not consider you to be in good overall health
  • You have signs or symptoms of heart failure
  • You have moderate to severe irregular heart rhythms
  • You have a history of chest pain caused by reduced blood flow to the heart (angina)
  • You have an implanted pacemaker, defibrillator, or any other device that would prevent you from having an MRI scan
  • You are on dialysis, have significantly reduced kidney function, or have a sudden kidney injury (if a recent kidney test isn't available, one will be done before your MRI)
  • You are pregnant or breastfeeding
  • You have taken part in a study involving an experimental drug or device recently, or are currently enrolled in one
  • You are unable to sit upright with back support
  • You are unable to have a cardiac MRI scan using a special dye (contrast), or you have claustrophobia (fear of enclosed spaces)
  • You are unable to take part in exercise tests
  • You have been diagnosed with Type 1 or Type 2 Diabetes
  • You have any other condition or health issue that the study doctor believes would make it unsafe or unsuitable for you to participate (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Ronald G Crystal, MD, Weill Medical College of Cornell University

Phone: 646-962-5527

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
15 January 2015
Est. completion
1 August 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Level of troponin, BNP, and CPK in blood; echocardiogram; exercise-stress test

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov